MiR-31 suppresses lung adenocarcinoma cell proliferation through CDK1 and E2F2-mediated cell cycle arrest
Collectively, our study establishes miR-31 as a novel biomarker for LUAD proliferative potential and implicates the miR-31/CDK1-E2F2 network as a promising target for disrupting LUAD progression. These findings establish a miRNA-centric precision therapeutic paradigm for effectively suppressing oncogenic proliferation in LUAD.
Authors
- Shanshan Wang (ORCID: https://orcid.org/0000-0002-5819-9265)
- Yulin He
- Chenjing Lin
- Pan Sun
- Man Zhang
- Jizhuang Luo
- Yi Tian
- Kai Wang
Institutions
- Shanghai Jiao Tong University (CN)
- Shanghai Chest Hospital (CN)
- Fujian Provincial People's Hospital (CN)
- Fujian Provincial Hospital (CN)
- Dazhou Central Hospital (CN)
- Xiangyang Hospital of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2026-01-09
- DOI
- https://doi.org/10.1007/s12672-025-04362-6
- Primary Topic
- MicroRNA in disease regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00